Biopharma
Charles River Laboratories Reduces Workforce by 3% Amid Q2 Revenue Decline
Charles River Laboratories, workforce reduction, layoffs, Q2 revenue drop, biopharma industry, restructuring initiatives
BridgeBio Unveils GondolaBio with $300M Investment, Transfers Key Programs to Joint Venture
BridgeBio, GondolaBio, Joint Venture, $300M Investment, Genetic Therapies, Biopharma Startup
Evotec Announces Restructuring Plan Amid Research Spending Slowdown
Evotec, layoffs, restructuring, research spending slowdown, gene therapy, biopharma
Aeterna Zentaris Rebrands as COSCIENS Biopharma: A New Era in Biopharmaceuticals
Aeterna Zentaris, COSCIENS Biopharma, biopharmaceuticals, rebranding, name change, therapeutic development, diagnostic tests, Macrilen, adult growth hormone deficiency
Pharma Campaign Contributions, Vaccine Hiccups, and Lykos’ Moment of Truth
Pharma campaign contributions, vaccine hiccups, Lykos Therapeutics, MDMA-assisted treatment, FDA approvals, Q2 earnings, biopharma challenges
Sangamo Partners with Genentech for $1.9 Billion Neurology-Focused Deal Using Zinc Finger Technology
Sangamo, Genentech, zinc finger technology, neurology, Alzheimer’s disease, tau gene, biobucks, biopharma, gene therapy, Fabry disease
Biopharma Companies uniQure and Arbutus Announce Workforce Reductions to Focus on Priority Programs
uniQure, Arbutus Biopharma, layoffs, workforce reduction, biopharma, priority programs, gene therapy, clinical trials
Biosecure Lawmakers Target China Studies in New Regulatory Push
Biosecure Act, China studies, clinical trials, biopharma, U.S.-China relations, drug production, national security, pharmaceutical supply chain
Biopharma Layoff Tracker 2024: Anokion, GlycoMimetics, Relay and More Cut Staff
Biopharma, Layoffs, 2024, Anokion, GlycoMimetics, Relay, Restructuring, Job Cuts, Industry Trends
Biopharma Layoff Tracker 2024: Industry-Wide Job Cuts Continue
Biopharma, Layoffs, Job Cuts, Industry Tracker, 2024